Join us for the Philip R. Greipp, MD Mayo Clinic Patient Symposium on Multiple Myeloma, AL Amyloidosis & Waldenström Macroglobulinemia.View quoted post on X
📅 Oct. 31, 2026
📍 Eagan, MN + limited virtual option (QR code below)
🎟️ Free registration
Learn. Connect. Ask questions. Find support.
@Myeloma_mSMART @MyelomaDrKapoor @VincentRK @ADispenzieri @IMFnurseMyeloma @Taxkourel @RahmaWarsameMD
#MultipleMyeloma #Amyloidosis #Waldenstrom
Taxiarchis Kourelis
@Taxkourel
Trying to be a good husband, father and doctor as much as I can. Hate all things Congophilic.Tweets are my own.
277 Following 972 Followers 3.1K Posts
Latest posts 5
@VisramAlissa very nice work!
Huge kudos to Dr. Visram from @HamiltonMyeloma for getting this analysis completed with @End_myeloma @SurbhiSidanaMD as part of her ASH CRTI project @HamHealthSci @McMasterUView quoted post on X
As in AL, there may be a limit to targeting the amyloidogenic protein alone. We need to better understand mechanisms of tissue injury, including metabolic dysregulation, complement, matrix remodeling and fibrosis, and build tissue-based correlatives into #amyloidosis trials.
A thoughtful commentary by @BrettSperryMD et alView quoted post on X
Lots of lessons to learn from cardio ttransform that will inform the whole field and practice
Most people carrying an amyloidogenic protein never develop amyloidosis. Understanding why is the key to screening the right people at the right time. Our ISA workshop perspective is now out in Amyloid. #amyloidosis
🔗 doi.org/10.1080/135061…
🔗 doi.org/10.1080/135061…
Very useful paper for every day practice and to set expectations with patients
British Journal of Haematology | onlinelibrary.wiley.com/doi/10.1111/bj…View quoted post on X